PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex.

PubWeight™: 1.82‹?› | Rank: Top 3%

🔗 View Article (PMC 85837)

Published in Mol Cell Biol on July 01, 2000

Authors

M C Bonnet1, R Weil, E Dam, A G Hovanessian, E F Meurs

Author Affiliations

1: Unité de Virologie et d'Immunologie Cellulaire, URA CNRS 1930, Institut Pasteur, 75724 Paris Cedex 15, France.

Articles citing this

Autophagy and the integrated stress response. Mol Cell (2010) 11.21

Interferon-inducible antiviral effectors. Nat Rev Immunol (2008) 9.68

Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol (2000) 5.44

Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev (2006) 4.13

Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell (2010) 4.01

Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol Cell Biol (2003) 3.01

A comprehensive map of the toll-like receptor signaling network. Mol Syst Biol (2006) 2.89

Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog (2013) 1.74

TRAF family proteins link PKR with NF-kappa B activation. Mol Cell Biol (2004) 1.40

Diversion of stress granules and P-bodies during viral infection. Virology (2013) 1.33

The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J (2004) 1.29

Molecular basis for PKR activation by PACT or dsRNA. Proc Natl Acad Sci U S A (2006) 1.28

Protein kinase PKR mediates the apoptosis induction and growth restriction phenotypes of C protein-deficient measles virus. J Virol (2008) 1.18

Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain. J Virol (2001) 1.13

The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR). Biochem J (2002) 1.09

Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses. Virology (2009) 1.08

Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs. Mol Cell Biol (2001) 1.07

Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. EMBO J (2001) 1.07

PKR-dependent inflammatory signals. Sci Signal (2012) 1.07

The role of chemokines during herpes simplex virus-1 infection. Front Biosci (2008) 1.06

MDA5 localizes to stress granules, but this localization is not required for the induction of type I interferon. J Virol (2013) 1.05

dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection. Viruses (2012) 1.05

Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. Nat Chem Biol (2013) 1.04

Regulation of stress granules and P-bodies during RNA virus infection. Wiley Interdiscip Rev RNA (2013) 1.03

The stress granule protein G3BP1 recruits protein kinase R to promote multiple innate immune antiviral responses. J Virol (2014) 1.00

The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G₁ arrest. Cell Cycle (2012) 0.99

Potential role for snoRNAs in PKR activation during metabolic stress. Proc Natl Acad Sci U S A (2015) 0.96

The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R. J Virol (2010) 0.95

Prevention of the β-amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primary murine mixed co-cultures. J Neuroinflammation (2011) 0.93

Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation. PLoS One (2011) 0.92

Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation. J Neuroinflammation (2014) 0.90

Okadaic acid activates the PKR pathway and induces apoptosis through PKR stimulation in MG63 osteoblast-like cells. Int J Oncol (2013) 0.90

Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease. Mediators Inflamm (2015) 0.89

The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells. Mol Biol Cell (2010) 0.86

Ubiquitination-mediated regulation of interferon responses. Growth Factors (2012) 0.86

Quantitative Proteomic Analysis of BHK-21 Cells Infected with Foot-and-Mouth Disease Virus Serotype Asia 1. PLoS One (2015) 0.85

Role of p58IPK in Endoplasmic Reticulum Stress-associated Apoptosis and Inflammation. J Ophthalmic Vis Res (2014) 0.83

Activation of stress response pathways promotes formation of antiviral granules and restricts virus replication. Mol Cell Biol (2014) 0.81

Dual activators of protein kinase R (PKR) and protein kinase R-like kinase PERK identify common and divergent catalytic targets. Chembiochem (2013) 0.81

RAX is required for fly neuronal development and mouse embryogenesis. Mech Dev (2008) 0.81

Increased expression of the dsRNA-activated protein kinase PKR in breast cancer promotes sensitivity to doxorubicin. PLoS One (2012) 0.81

Neuroinflammation and Aβ accumulation linked to systemic inflammation are decreased by genetic PKR down-regulation. Sci Rep (2015) 0.80

Old target new approach: an alternate NF-kappaB activation pathway via translation inhibition. Mol Cell Biochem (2009) 0.80

Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal. World J Diabetes (2015) 0.80

The kinase activity of PKR represses inflammasome activity. Cell Res (2016) 0.79

Cytoplasmic RNA Granules and Viral Infection. Annu Rev Virol (2014) 0.79

Protein kinase regulated by dsRNA downregulates the interferon production in dengue virus- and dsRNA-stimulated human lung epithelial cells. PLoS One (2013) 0.79

Inhibition of type I interferon production via suppressing IKK-gamma expression: a new strategy for counteracting host antiviral defense by influenza A viruses? J Proteome Res (2011) 0.78

HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2. Aging (Albany NY) (2010) 0.78

p58(IPK) suppresses NLRP3 inflammasome activation and IL-1β production via inhibition of PKR in macrophages. Sci Rep (2016) 0.78

Regulation of PACT-Mediated Protein Kinase Activation by the OV20.0 Protein of Orf Virus. J Virol (2015) 0.76

Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NF-κB/c-Myc Pathway in Pancreatic β cells. Mol Med (2015) 0.76

The Role of PKR as a Potential Target for Treating Cardiovascular Diseases. Curr Cardiol Rev (2017) 0.75

Positional effect of phosphorylation sites 266 and 267 in the cytoplasmic domain of the E2 protein of hepatitis C virus 3a genotype: interferon resistance analysis via sequence alignment. Virol J (2011) 0.75

Associations among Genotype 1b Hepatitis C Virus Core Protein, Protein Kinase R, and Signal Transducer and Activator of Transcription 3. Hepat Mon (2010) 0.75

PKR involvement in Alzheimer's disease. Alzheimers Res Ther (2017) 0.75

Articles cited by this

The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol (1996) 22.30

Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature (1999) 16.97

Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science (1991) 13.85

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature (1997) 11.31

The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell (1997) 8.74

Translational control in mammalian cells. Annu Rev Biochem (1991) 8.36

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev (1995) 7.36

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell (1990) 7.12

Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J (1995) 6.94

Identification and characterization of an IkappaB kinase. Cell (1997) 6.71

MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature (1997) 6.53

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell (1998) 6.48

Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A (1989) 6.32

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science (1999) 6.20

IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature (1998) 6.15

Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control. Mol Cell Biol (1998) 5.66

TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity (1996) 5.45

Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science (1999) 5.15

Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A (1994) 4.53

Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology (1991) 4.45

RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J (1996) 4.33

Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell (1993) 4.10

Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell (1997) 3.91

Limb and skin abnormalities in mice lacking IKKalpha. Science (1999) 3.85

Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit. Cell (1992) 3.73

Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J (1992) 3.65

The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res (1997) 3.54

Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J (1997) 3.34

Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase. Eur J Biochem (1999) 2.99

Interferon regulatory factors: the next generation. Gene (1999) 2.98

2-Aminopurine selectively inhibits the induction of beta-interferon, c-fos, and c-myc gene expression. Science (1988) 2.97

Mammalian eukaryotic initiation factor 2 alpha kinases functionally substitute for GCN2 protein kinase in the GCN4 translational control mechanism of yeast. Proc Natl Acad Sci U S A (1993) 2.90

Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol (1992) 2.80

Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol Cell Biol (1999) 2.77

NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol (1997) 2.76

JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74

NF-kappaB activation: the I kappaB kinase revealed? Cell (1997) 2.73

Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (1995) 2.61

Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A (1998) 2.59

RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem (1998) 2.58

Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system. Mol Cell Biol (1991) 2.55

NF-kappa B and rel proteins in innate immunity. Adv Immunol (1995) 2.53

The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J Interferon Res (1989) 2.39

Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J (1997) 2.16

Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells. Proc Natl Acad Sci U S A (1985) 2.09

Translational control: the cancer connection. Int J Biochem Cell Biol (1999) 1.95

Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr Biol (1999) 1.85

Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol (2000) 1.83

Characterization of the hemin-sensitive eukaryotic initiation factor 2alpha kinase from mouse nonerythroid cells. J Biol Chem (1998) 1.83

Apoptosis: an innate immune response to virus infection. Trends Microbiol (1999) 1.82

Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. EMBO J (1997) 1.78

Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science (1994) 1.72

Cloning and characterization of a cDNA encoding a protein synthesis initiation factor-2alpha (eIF-2alpha) kinase from Drosophila melanogaster. Homology To yeast GCN2 protein kinase. J Biol Chem (1997) 1.66

Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol Cell Biol (1999) 1.54

Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J Biol Chem (1996) 1.46

RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. J Virol (1998) 1.44

Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3. J Virol (1994) 1.27

HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells. Oncogene (1993) 1.17

Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Mol Cell Biol (1997) 1.15

The kinase insert domain of interferon-induced protein kinase PKR is required for activity but not for interaction with the pseudosubstrate K3L. J Biol Chem (1996) 1.10

Human PKR transfected into murine cells stimulates expression of genes under control of the HIV1 or HTLV-I LTR. Virology (1995) 0.95

Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR. J Virol (1997) 0.91

2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells. Blood (1998) 0.78

Articles by these authors

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell (1990) 7.12

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell (1998) 6.48

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science (1993) 6.16

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

The dsRNA protein kinase PKR: virus and cell control. Biochimie (2007) 3.67

Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J (1992) 3.65

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Induction of cellular DNA synthesis by polyoma virus. Proc Natl Acad Sci U S A (1965) 3.63

Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A (1993) 3.62

Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol (1998) 2.94

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92

Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol (1992) 2.80

Successful liver transplantation from crossmatch-positive donors. Transplant Proc (1981) 2.80

Transcription of the polyoma virus genome: synthesis and cleavage of giant late polyoma-specific RNA. Proc Natl Acad Sci U S A (1971) 2.77

Studies in Anaphylaxis: XIII. The Activation of Antibody by the Cell. J Med Res (1915) 2.71

Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA. Nature (1977) 2.68

Two forms of simian-virus-40-specific T-antigen in abortive and lytic infection. Proc Natl Acad Sci U S A (1976) 2.67

Mouse cellular DNA enclosed in polyoma viral capsids (pseudovirions). Proc Natl Acad Sci U S A (1967) 2.64

A simplifying concept in tumor virology: virus-specific "pleiotropic effectors". Cold Spring Harb Symp Quant Biol (1975) 2.61

Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system. Mol Cell Biol (1991) 2.55

Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49

Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44

The cytopathic effect of HIV is associated with apoptosis. Virology (1991) 2.43

The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur J Biochem (1989) 2.42

V. Desensitization: Its Theoretical and Practical Significance. J Med Res (1913) 2.36

Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33

Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis. Nucleic Acids Res (1991) 2.33

Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J (1987) 2.17

Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells. Proc Natl Acad Sci U S A (1985) 2.09

Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc Natl Acad Sci U S A (1990) 2.05

Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med (1980) 2.00

Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science (1990) 1.93

Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing. J Virol (1989) 1.93

Amino acid sequence analysis of fragments generated by partial proteolysis from large simian virus 40 tumor antigen. J Biol Chem (1980) 1.92

Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature (1977) 1.88

Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol (2000) 1.83

Synthesis of an oligonucleotide inhibitor of protein synthesis in rabbit reticulocyte lysates analogous to that formed in extracts from interferon-treated cells. Eur J Biochem (1978) 1.79

The quality of life after liver transplantation. Transplant Proc (1979) 1.78

Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses (1993) 1.67

A study on the transcription of the polyoma viral genome. Proc Natl Acad Sci U S A (1970) 1.67

Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. Proc Natl Acad Sci U S A (1979) 1.66

"Early" virus-specific RNA may contain information necessary for chromosome replication and mitosis induced by Simian Virus 40. Proc Natl Acad Sci U S A (1973) 1.66

HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology (1994) 1.63

The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase. J Virol (1991) 1.63

Polyoma viral DNA replicated as a nucleoprotein complex in close association with the host cell chromatin. J Virol (1974) 1.62

Development of a suprahepatic recipient vena cava cuff for liver transplantation. Surg Gynecol Obstet (1979) 1.60

Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60

Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. J Biol Chem (1992) 1.57

HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology (1995) 1.56

Polyoma "tumor antigen": an activator of chromosome replication? Proc Natl Acad Sci U S A (1970) 1.55

Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies. AIDS (1999) 1.52

The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res (1999) 1.52

Biochemical evidence for induction by polyoma virus of replication of the chromosomes of mouse kidney cells. Proc Natl Acad Sci U S A (1969) 1.51

Liver replacement for pediatric patients. Pediatrics (1979) 1.51

The (2'-5') oligoadenylate (pppA2'-5'A2'-5'A) synthetase and protein kinase(s) from interferon-treated cells. Eur J Biochem (1979) 1.51

Viral 'tumor antigens': A novel type of mammalian regulator protein. Biochim Biophys Acta (1978) 1.49

Energy-dependent binding of dansylgalactosides to the beta-galactoside carrier protein. J Biol Chem (1975) 1.49

SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene (1989) 1.48

Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med (1992) 1.46

Two interferon-induced proteins are involved in the protein kinase complex dependent on double-stranded RNA. Cell (1985) 1.45

Further characterization of the protein kinase activity mediated by interferon in mouse and human cells. J Biol Chem (1984) 1.43

Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J Biol Chem (2001) 1.42

Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J Virol (2000) 1.41

An actin-destabilizing factor is present in human plasma. Experientia (1979) 1.41

A study on the mechanism of polyoma-induced activation of the cellular DNA-synthesizing apparatus. Synchronization by FUdR of virus-induced DNA synthesis. Arch Gesamte Virusforsch (1968) 1.41

Cryptococcosis after renal transplantation: report of ten cases. Surgery (1976) 1.41

Complete remission and possible immune tolerance after multidrug combination chemotherapy for cyclosporine-related lymphoma in a renal transplant recipient with acute pancreatitis. Transplantation (1991) 1.40

Decline in survival after liver transplantation. Arch Surg (1980) 1.39

Causes of death after kidney transplantation. JAMA (1983) 1.38

Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp Cell Res (1995) 1.37

Aseptic necrosis of bone following renal transplantation: experience in 194 transplant recipients and review of the literature. Medicine (Baltimore) (1978) 1.37

Excisional treatment of cavernous hemangioma of the liver. Ann Surg (1980) 1.37

Synthesis of the tumour antigen and the major capsid protein of simian virus 40 in a cell-free system derived from Escherichia coli. J Mol Biol (1976) 1.37

Plaque assay for polyoma virus on primary mouse kidney cell cultures. Appl Microbiol (1973) 1.35

Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med (1979) 1.34

Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J Biol Chem (1995) 1.34

Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. J Biol Chem (1994) 1.33

Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes. J Exp Med (1996) 1.32

Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-kappa B-independent pathway. J Biol Chem (2000) 1.32

Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res (1997) 1.31

Antiviral response and induction of specific proteins in cells treated with immune T (type II) interferon analogous to that from viral interferon (type I)-treated cells. Virology (1980) 1.31

Prevention of urological complications after kidney transplantation. Ann Surg (1971) 1.29

Well-done, grilled red meat increases the risk of colorectal adenomas. Cancer Res (1999) 1.27

Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers. J Virol (1990) 1.26

Liver transplantation of Budd-Chiari syndrome. JAMA (1976) 1.26

Interferon enhances 2-5A synthetase in embryonal carcinoma cells. Nature (1979) 1.25

Cryoglobulins. III. Further studies on the nature, incidence, clinical, diagnostic, prognostic, and immunopathologic significance of cryoproteins in renal disease. Q J Med (1975) 1.24

Synthesis of polyoma virus structural polypeptides in mouse kidney cells. Virology (1974) 1.21

Simian virus 40 and polyoma virus stimulate overall cellular RNA and protein synthesis. Proc Natl Acad Sci U S A (1980) 1.21

Thoracic duct drainage in organ transplantation: will it permit better immunosuppression? Transplant Proc (1979) 1.21

Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. Semin Immunol (1993) 1.20

p67K kinase in different tissues and plasma of control and interferon-treated mice. Virology (1982) 1.20

Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein. Virology (1989) 1.20

Continuous production of interferon in normal mice: effect of anti-interferon globulin, sex, age, strain and environment on the levels of 2-5A synthetase and p67K kinase. J Gen Virol (1985) 1.19